2/5
10:49 am
iclr
IQVIA slides after Q4 results as earnings outlook underwhelms [Seeking Alpha]
Medium
Report
IQVIA slides after Q4 results as earnings outlook underwhelms [Seeking Alpha]
1/27
07:23 am
iclr
ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership [Yahoo! Finance]
Low
Report
ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership [Yahoo! Finance]
1/27
07:15 am
iclr
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
Low
Report
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
1/22
10:58 am
iclr
Icon (NASDAQ:ICLR) had its "hold" rating reaffirmed by analysts at TD Cowen.
Low
Report
Icon (NASDAQ:ICLR) had its "hold" rating reaffirmed by analysts at TD Cowen.
1/22
12:16 am
iclr
ICON PLC (ICLR) Trades Below Normal Earnings Despite Strong Fundamentals [Yahoo! Finance]
Low
Report
ICON PLC (ICLR) Trades Below Normal Earnings Despite Strong Fundamentals [Yahoo! Finance]
1/21
07:04 pm
iclr
An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 26% Undervalued [Yahoo! Finance]
Low
Report
An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 26% Undervalued [Yahoo! Finance]
1/9
10:09 am
iclr
Icon (NASDAQ:ICLR) was given a new $217.00 price target on by analysts at Robert W. Baird.
Low
Report
Icon (NASDAQ:ICLR) was given a new $217.00 price target on by analysts at Robert W. Baird.
1/9
09:13 am
iclr
Icon (NASDAQ:ICLR) was given a new $216.00 price target on by analysts at Mizuho.
Medium
Report
Icon (NASDAQ:ICLR) was given a new $216.00 price target on by analysts at Mizuho.
1/8
07:09 am
iclr
Icon (NASDAQ:ICLR) was given a new $222.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Icon (NASDAQ:ICLR) was given a new $222.00 price target on by analysts at Truist Financial Corporation.
1/5
07:37 am
iclr
Artisan Mid Cap Value Fund Increased its Stake in ICON Public Limited Company (ICLR). Here's Why [Yahoo! Finance]
Medium
Report
Artisan Mid Cap Value Fund Increased its Stake in ICON Public Limited Company (ICLR). Here's Why [Yahoo! Finance]
1/5
07:17 am
iclr
Icon (NASDAQ:ICLR) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Medium
Report
Icon (NASDAQ:ICLR) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
12/22
09:43 am
iclr
Clinical Trial Supply & Logistics Market Outlook, 2025-2032 - A 48 Billion-Dollar Opportunity Featuring Strategic Insights Into 43 Key Companies [Yahoo! Finance]
Low
Report
Clinical Trial Supply & Logistics Market Outlook, 2025-2032 - A 48 Billion-Dollar Opportunity Featuring Strategic Insights Into 43 Key Companies [Yahoo! Finance]
12/17
09:02 am
iclr
Here's Why ICON Plc. (ICLR) Gained +20.3% in Q3 [Yahoo! Finance]
Low
Report
Here's Why ICON Plc. (ICLR) Gained +20.3% in Q3 [Yahoo! Finance]
12/16
04:37 pm
iclr
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
Icon (NASDAQ:ICLR) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings.
12/15
10:08 am
iclr
Icon (NASDAQ:ICLR) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $195.00 price target on the stock.
Low
Report
Icon (NASDAQ:ICLR) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating. They now have a $195.00 price target on the stock.
12/15
07:19 am
iclr
Icon (NASDAQ:ICLR) was given a new $200.00 price target on by analysts at Barclays PLC.
Low
Report
Icon (NASDAQ:ICLR) was given a new $200.00 price target on by analysts at Barclays PLC.
12/10
10:39 am
iclr
BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call [Yahoo! Finance]
Low
Report
BMO Capital Maintains Outlook On ICON Public Limited Company (ICLR) After Management Call [Yahoo! Finance]
12/9
07:15 am
iclr
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
Low
Report
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
12/2
07:15 am
iclr
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
Low
Report
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
11/27
06:18 am
iclr
Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
Icon (NASDAQ:ICLR) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
11/26
02:09 pm
iclr
Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Icon (NASDAQ:ICLR) had its "hold (c-)" rating reaffirmed by analysts at
Weiss Ratings.
11/24
08:32 pm
iclr
FMI Global Equity Q3 2025 Commentary [Seeking Alpha]
Medium
Report
FMI Global Equity Q3 2025 Commentary [Seeking Alpha]
11/21
07:04 pm
iclr
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
Low
Report
Icon PLC (ICLR) Down 12.2% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]
11/14
04:43 pm
iclr
ICON Public Limited Company (ICLR) Soared on Robust Performance [Yahoo! Finance]
Medium
Report
ICON Public Limited Company (ICLR) Soared on Robust Performance [Yahoo! Finance]
11/13
08:11 am
iclr
Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock.
Low
Report
Icon (NASDAQ:ICLR) is now covered by analysts at BMO Capital Markets. They set a "market perform" rating and a $175.00 price target on the stock.